JP2016519165A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519165A5 JP2016519165A5 JP2016515318A JP2016515318A JP2016519165A5 JP 2016519165 A5 JP2016519165 A5 JP 2016519165A5 JP 2016515318 A JP2016515318 A JP 2016515318A JP 2016515318 A JP2016515318 A JP 2016515318A JP 2016519165 A5 JP2016519165 A5 JP 2016519165A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- methyl
- nitrogen atoms
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 230000037361 pathway Effects 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229920006395 saturated elastomer Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- -1 1,3-dimethyl-2,6-dioxo-2,3-dihydro -1H- purine -7 (6H) - yl Chemical group 0.000 description 4
- 239000013067 intermediate product Substances 0.000 description 4
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
- 238000006751 Mitsunobu reaction Methods 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- WZBKGWBHAPBSBF-UHFFFAOYSA-N 1,3,8-trimethyl-7h-purine-2,6-dione Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=C(C)N2 WZBKGWBHAPBSBF-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1309333.1A GB201309333D0 (en) | 2013-05-23 | 2013-05-23 | Purine diones as WNT pathway modulators |
| GB1309333.1 | 2013-05-23 | ||
| PCT/SG2014/000217 WO2014189466A1 (en) | 2013-05-23 | 2014-05-19 | Purine diones as wnt pathway modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519165A JP2016519165A (ja) | 2016-06-30 |
| JP2016519165A5 true JP2016519165A5 (enExample) | 2017-04-06 |
| JP6506742B2 JP6506742B2 (ja) | 2019-04-24 |
Family
ID=48784655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515318A Active JP6506742B2 (ja) | 2013-05-23 | 2014-05-19 | Ｗｎｔ経路モジュレーターとしてのプリンジオン |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US9926320B2 (enExample) |
| EP (1) | EP2999699B1 (enExample) |
| JP (1) | JP6506742B2 (enExample) |
| KR (2) | KR102153989B1 (enExample) |
| CN (2) | CN109776537B (enExample) |
| AU (2) | AU2014269134B2 (enExample) |
| BR (1) | BR112015029182B1 (enExample) |
| CA (1) | CA2912757C (enExample) |
| DK (1) | DK2999699T3 (enExample) |
| ES (1) | ES2802923T3 (enExample) |
| GB (1) | GB201309333D0 (enExample) |
| SG (1) | SG11201509593TA (enExample) |
| WO (1) | WO2014189466A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201309333D0 (en) | 2013-05-23 | 2013-07-10 | Agency Science Tech & Res | Purine diones as WNT pathway modulators |
| GB201322334D0 (en) * | 2013-12-17 | 2014-01-29 | Agency Science Tech & Res | Maleimide derivatives as modulators of WNT pathway |
| TWI676626B (zh) * | 2014-04-23 | 2019-11-11 | 美商美國禮來大藥廠 | 抑制瞬時受體電位ａ１離子通道 |
| EP3193880B1 (en) | 2014-09-19 | 2020-03-25 | Eli Lilly and Company | Inhibiting the transient receptor potential a1 ion channel |
| CN105440034B (zh) * | 2015-11-16 | 2017-08-15 | 山东罗欣药业集团股份有限公司 | 一种利格列汀及其中间体的制备方法 |
| US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
| CN106632332B (zh) * | 2016-09-26 | 2018-07-06 | 杭州新博思生物医药有限公司 | 一种伊曲茶碱的制备方法 |
| US11186581B2 (en) | 2017-09-14 | 2021-11-30 | Agency For Science, Technology And Research | 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-hydroxyphenyl)pyridazin-3-yl)acetamide as a Wnt pathway modulator |
| CA3088551C (en) | 2018-01-31 | 2023-01-24 | Eli Lilly And Company | Inhibiting the transient receptor potential a1 ion channel |
| US10961534B2 (en) | 2018-07-13 | 2021-03-30 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods of treating porphyria |
| WO2020069344A1 (en) | 2018-09-28 | 2020-04-02 | Children's Medical Center Corporation | Treating atopic dermatitis by targeting the wnt pathway |
| WO2020236083A1 (en) * | 2019-05-22 | 2020-11-26 | Agency For Science, Technology And Research | Oral formulations, methods of manufacture and uses thereof |
| US20220211715A1 (en) * | 2019-05-22 | 2022-07-07 | Agency For Science, Technology And Research | Pharmaceutical combination |
| CN114072408B (zh) * | 2019-07-08 | 2023-05-12 | 南京明德新药研发有限公司 | 作为porcupine抑制剂的化合物及其应用 |
| WO2021141538A1 (en) * | 2020-01-08 | 2021-07-15 | Agency For Science, Technology And Research | Combination therapy |
| EP4361153A4 (en) | 2021-06-25 | 2025-07-02 | Korea Res Inst Chemical Tech | NOVEL BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF |
| WO2023072263A1 (zh) * | 2021-10-29 | 2023-05-04 | 南京明德新药研发有限公司 | 5-取代的吡啶-2(1h)-酮类化合物及其应用 |
| CN114671875A (zh) * | 2022-04-27 | 2022-06-28 | 成都施贝康生物医药科技有限公司 | 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途 |
| CN120737092B (zh) * | 2025-09-05 | 2025-11-14 | 利诚检测认证集团股份有限公司 | 别嘌醇半抗原及其制备方法、人工抗原、抗体及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA71971C2 (en) | 1999-06-04 | 2005-01-17 | Agoron Pharmaceuticals Inc | Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases |
| EP1962855B1 (en) * | 2005-12-22 | 2013-08-21 | Hydra Biosciences, Inc. | Trpa1 inhibitors for treating pain |
| WO2009002933A1 (en) * | 2007-06-22 | 2008-12-31 | Hydra Biosciences, Inc. | Methods and compositions for treating disorders |
| JP2011504462A (ja) * | 2007-11-02 | 2011-02-10 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | 腫瘍の予防および治療のための方法および化合物 |
| AU2008345225A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2009140519A1 (en) * | 2008-05-14 | 2009-11-19 | Hydra Biosciences, Inc. | Compounds and compositions for treating chemical warfare agent-induced injuries |
| WO2010036821A1 (en) * | 2008-09-24 | 2010-04-01 | Hydra Biosciences, Inc. | Methods and compositions for treating respiratory disorders |
| US8362025B2 (en) | 2008-12-22 | 2013-01-29 | Hydra Biosciences, Inc. | Compositions useful for treating disorders related to TRPA1 |
| UA103918C2 (en) * | 2009-03-02 | 2013-12-10 | Айерем Элелси | N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators |
| US8377970B2 (en) | 2009-10-08 | 2013-02-19 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel |
| US8993612B2 (en) | 2009-10-08 | 2015-03-31 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| UY33469A (es) | 2010-06-29 | 2012-01-31 | Irm Llc Y Novartis Ag | Composiciones y metodos para modular la via de señalizacion de wnt |
| KR101591153B1 (ko) * | 2010-12-20 | 2016-02-02 | 그렌마크 파머수티칼스 에스. 아. | Trpa1 길항제로서의 2-아미노-4-아릴티아졸 화합물 |
| RU2014100744A (ru) * | 2011-06-13 | 2015-07-20 | Гленмарк Фармасьютикалс С.А. | Лечение респираторных нарушений с помощью trpa1 антагонистов |
| JP5659098B2 (ja) * | 2011-07-19 | 2015-01-28 | 株式会社東芝 | 半導体装置の製造方法 |
| US20140148423A1 (en) * | 2011-07-25 | 2014-05-29 | Glenmark Pharmaceuticals S.A. | Pharmaceutical composition comprising a trpa1 antagonist and a steroid |
| KR20140073496A (ko) | 2011-08-09 | 2014-06-16 | 하이드라 바이오사이언시스, 인코포레이티드 | 일과성 수용체 잠재 이온채널 trpa1의 억제 |
| HUE041576T2 (hu) * | 2011-09-14 | 2019-05-28 | Samumed Llc | Indazol-3-karboxamid-származékok és alkalmazásuk Wnt/b-katenin szignalizáló útvonal inhibitorokként |
| NZ728724A (en) | 2012-05-11 | 2018-03-23 | Reset Therapeutics Inc | Carbazole-containing sulfonamides as cryptochrome modulators |
| GB201309333D0 (en) | 2013-05-23 | 2013-07-10 | Agency Science Tech & Res | Purine diones as WNT pathway modulators |
-
2013
- 2013-05-23 GB GBGB1309333.1A patent/GB201309333D0/en not_active Ceased
-
2014
- 2014-05-19 CN CN201910142080.7A patent/CN109776537B/zh active Active
- 2014-05-19 JP JP2016515318A patent/JP6506742B2/ja active Active
- 2014-05-19 SG SG11201509593TA patent/SG11201509593TA/en unknown
- 2014-05-19 CN CN201480041283.2A patent/CN105452248A/zh active Pending
- 2014-05-19 BR BR112015029182-1A patent/BR112015029182B1/pt active IP Right Grant
- 2014-05-19 CA CA2912757A patent/CA2912757C/en active Active
- 2014-05-19 WO PCT/SG2014/000217 patent/WO2014189466A1/en not_active Ceased
- 2014-05-19 KR KR1020197038593A patent/KR102153989B1/ko active Active
- 2014-05-19 DK DK14801575.3T patent/DK2999699T3/da active
- 2014-05-19 KR KR1020157035961A patent/KR102062262B1/ko active Active
- 2014-05-19 AU AU2014269134A patent/AU2014269134B2/en active Active
- 2014-05-19 EP EP14801575.3A patent/EP2999699B1/en active Active
- 2014-05-19 US US14/893,172 patent/US9926320B2/en active Active
- 2014-05-19 ES ES14801575T patent/ES2802923T3/es active Active
-
2017
- 2017-08-03 US US15/668,260 patent/US10472360B2/en active Active
- 2017-08-28 AU AU2017219132A patent/AU2017219132B2/en active Active
-
2018
- 2018-02-20 US US15/899,675 patent/US10526335B2/en active Active
-
2019
- 2019-12-16 US US16/716,268 patent/US10844063B2/en active Active
-
2020
- 2020-11-20 US US17/100,474 patent/US11555037B2/en active Active
-
2022
- 2022-12-08 US US18/077,921 patent/US12559495B2/en active Active